Zhitong Finance App News, Nuo Cheng Jianhua (09969) announced that the company recently received a “Notice Letter on the End of Stock Holdings Reduction” issued by Executive Director, Chairman of the Board, and CEO Jisong Cui (Cui Jisong), Executive Director and Senior Vice President of Hematoma Medical Research and Clinical Development Renbin Zhao (Zhao Renbin), and Chief Technology Officer Xiang Yang Chen (Chen Xiangyang). As of the disclosure date of this announcement, Chairman Cui Jisong, Executive Director Zhao Renbin, and Chief Technical Officer Chen Xiangyang have combined to reduce their holdings through centralized bidding 3187,500 A-shares.

Among them, Jisong CuiJiSongCui (Cui Jisong) reduced its A-share holdings by a total of 206.25 million shares through centralized bidding, accounting for 0.0117% of the company's current total share capital; Renbin Zhao (Zhao Renbin) reduced its A-share holdings by 50,000 shares through centralized bidding, accounting for 0.0028% of the company's current total share capital; and XiangyangChen (Chen Xiangyang) reduced its A-share holdings by a total of 62,500 shares through centralized bidding, accounting for 62,500 shares of the reduction in the number of shares 0.0035% of the company's current total share capital.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.